The study on L1CAM+/CD133+ ovarian CSCs showed also, through the genetic manipulation of ovarian cancer cell lines, that L1CAM is causally involved in CSC-associated radioresistance as well as in self-renewal and tumor initiation. This evidence concerns the gene L1CAM and ovarian cancer.